Company · CIK 0001681087 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Tectonic Therapeutic, Inc. · TECX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
No reported common-stock activity in this period.
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 3, 2026 AForm 4 → | Sep 8, 4:45 pm EDT | Marc SchwabishChief Business Officer | 17,750 | — | — | 17,750 | — | |
| Sep 3, 2026 AForm 4 → | Sep 8, 4:45 pm EDT | Peter McNamaraChief Scientific Officer | 21,000 | — | — | 21,000 | — | |
| Sep 3, 2026 AForm 4 → | Sep 8, 4:45 pm EDT | Daniel LochnerChief Financial Officer | 24,250 | — | — | 24,250 | — | |
| Sep 3, 2026 AForm 4 → | Sep 8, 4:45 pm EDT | Marcella K. RuddyChief Medical Officer | 24,250 | — | — | 24,250 | — | |
| Sep 3, 2026 AForm 4 → | Sep 8, 4:45 pm EDT | Alise ReicinChief Executive Officer, Director | 69,250 | — | — | 69,250 | — |